Smith & Nephew PLC
SNN32.845USD
+0.145+0.44%
종가 12/19, 16:00（ET）시세는 15분 지연됩니다
14.39B시가총액
29.22P/E TTM
자세한 내용은 Smith & Nephew PLC 회사
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew PLC 정보
종목 코드 SNN
회사 이름Smith & Nephew PLC
상장일Sep 18, 2087
CEONath (Deepak S)
직원 수17349
유형Depository Receipt
회계 연도 종료Sep 18
주소Building 5
도시WATFORD
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United Kingdom
우편 번호WD18 8YE
전화4401923477100
웹사이트https://www.smith-nephew.com/
종목 코드 SNN
상장일Sep 18, 2087
CEONath (Deepak S)
Smith & Nephew PLC의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+1.08%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+28.58%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.27K
+0.95%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.14K
+2.62%
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
기타
1.90B
32.62%
지역별USD
이름
수익
비율
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
사업별
지역별
사업별USD
이름
수익
비율
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
기타
1.90B
32.62%
주식 보유 통계
마지막 업데이트: Tue, Nov 18
마지막 업데이트: Tue, Nov 18
주주
주주 유형
주주
주주
비율
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
기타
97.55%
주주
주주
비율
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
기타
97.55%
주주 유형
주주
비율
Investment Advisor
3.66%
Research Firm
2.01%
Investment Advisor/Hedge Fund
1.51%
Hedge Fund
0.27%
Family Office
0.17%
Family Office
0.17%
Pension Fund
0.15%
Family Office
0.12%
Individual Investor
0.01%
기타
91.94%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
458
32.77M
7.72%
-12.10M
2025Q2
468
34.86M
7.96%
-12.17M
2025Q1
470
32.31M
7.38%
-15.13M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
2023Q2
453
39.60M
9.07%
-7.09M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BMO Capital Markets (US)
3.20M
0.75%
+2.62M
+455.42%
Jun 30, 2025
River Road Asset Management, LLC
3.18M
0.75%
+270.48K
+9.30%
Jun 30, 2025
Scharf Investments, LLC
2.08M
0.49%
+6.99K
+0.34%
Jun 30, 2025
Brandes Investment Partners, L.P.
1.60M
0.38%
+63.78K
+4.14%
Jun 30, 2025
Optiver Holding B.V.
1.15M
0.27%
+1.01M
+714.32%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
1.08M
0.25%
-18.79K
-1.72%
Jun 30, 2025
Parametric Portfolio Associates LLC
971.46K
0.23%
-1.36K
-0.14%
Jun 30, 2025
BNP Paribas Securities Corp. North America
644.52K
0.15%
+505.93K
+365.06%
Jun 30, 2025
Morgan Stanley & Co. LLC
823.55K
0.19%
+676.68K
+460.75%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Brandes International ETF
1.07%
ALPS Disruptive Technologies ETF
0.93%
ActivePassive International Equity ETF
0.2%
Avantis Responsible International Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.11%
Avantis International Equity ETF
0.07%
DFA Dimensional International Core Equity 2 ETF
0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
SGI Enhanced Global Income ETF
0%
Brandes International ETF
비율1.07%
ALPS Disruptive Technologies ETF
비율0.93%
ActivePassive International Equity ETF
비율0.2%
Avantis Responsible International Equity ETF
비율0.12%
SP Funds S&P World (ex-US) ETF
비율0.11%
Avantis International Equity ETF
비율0.07%
DFA Dimensional International Core Equity 2 ETF
비율0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
비율0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
비율0.01%
SGI Enhanced Global Income ETF
비율0%
주식 배당금
지난 5년 동안 총
1.64B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Aug 05, 2025
SNN.NB Final Cash Dividend of gross USD 0.3 paid on Nov 07, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Nov 07, 2025
Oct 03, 2025
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Smith & Nephew PLC의 상위 5대 주주는 누구인가요?
Smith & Nephew PLC의 상위 5대 주주는 다음과 같습니다:
BMO Capital Markets (US)는 3.20M주의 주식을 보유하고 있으며, 전체 주식의 0.75%를 차지합니다.
River Road Asset Management, LLC는 3.18M주의 주식을 보유하고 있으며, 전체 주식의 0.75%를 차지합니다.
Scharf Investments, LLC는 2.08M주의 주식을 보유하고 있으며, 전체 주식의 0.49%를 차지합니다.
Brandes Investment Partners, L.P.는 1.60M주의 주식을 보유하고 있으며, 전체 주식의 0.38%를 차지합니다.
Optiver Holding B.V.는 1.15M주의 주식을 보유하고 있으며, 전체 주식의 0.27%를 차지합니다.
BMO Capital Markets (US)는 3.20M주의 주식을 보유하고 있으며, 전체 주식의 0.75%를 차지합니다.
River Road Asset Management, LLC는 3.18M주의 주식을 보유하고 있으며, 전체 주식의 0.75%를 차지합니다.
Scharf Investments, LLC는 2.08M주의 주식을 보유하고 있으며, 전체 주식의 0.49%를 차지합니다.
Brandes Investment Partners, L.P.는 1.60M주의 주식을 보유하고 있으며, 전체 주식의 0.38%를 차지합니다.
Optiver Holding B.V.는 1.15M주의 주식을 보유하고 있으며, 전체 주식의 0.27%를 차지합니다.
Smith & Nephew PLC의 상위 3대 주주 유형은 무엇인가요?
Smith & Nephew PLC의 주요 주주 유형 상위 3가지는
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC입니다.
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC입니다.
Smith & Nephew PLC(SNN)의 주식을 보유한 기관은 몇 개입니까?
2025Q3 기준으로, Smith & Nephew PLC의 주식을 보유한 기관은 총 458곳이며, 이들이 보유한 주식의 총 가치는 약 32.77M로 전체 발행 주식의 7.72%를 차지합니다. 이는 2025Q2 대비 -0.24% 증가한 수치입니다.
Smith & Nephew PLC의 최대 수익원은 무엇인가요?
FY2024 기준, Smith & Nephew PLC의 Sports Medicine Joint Repair 부문이 가장 높은 매출을 기록했으며, 금액은 982.00M로 전체 매출의 16.90%를 차지했습니다.
